Kyle Gavulic, MPhil
he/him/his
About
Research
Publications
2026
Dementia Diagnosis Underreporting and Care Engagement and Planning Among Older Adults.
Qian Y, Gavulic KA, Chen X. Dementia Diagnosis Underreporting and Care Engagement and Planning Among Older Adults. JAMA Netw Open 2026, 9: e2631167. PMID: 42646835, DOI: 10.1001/jamanetworkopen.2026.31167.Peer-Reviewed Original Research“Conversion Therapy” in the US—Progress, Missed Opportunities, and Future Directions
Gavulic K, Pachankis J, Aaron D. “Conversion Therapy” in the US—Progress, Missed Opportunities, and Future Directions. JAMA Pediatrics 2026, 180: 599-600. PMID: 41910987, DOI: 10.1001/jamapediatrics.2026.0394.Commentaries, Editorials and Letters
2025
Presidential Powers And LGBTQI+ Equity: Advances And Rollbacks
Gavulic KA, Ferrara CF, Aaron DG, Gonzales G. Presidential Powers And LGBTQI+ Equity: Advances And Rollbacks. Health Affairs Forefront. 31 Mar 2025. DOI: 10.1377/forefront.20250324.892969Commentaries, Editorials and Letters
2024
Medicare Eligibility and Changes in Coverage, Access to Care, and Health by Sexual Orientation and Gender Identity
Gavulic K, Wallace J. Medicare Eligibility and Changes in Coverage, Access to Care, and Health by Sexual Orientation and Gender Identity. JAMA Health Forum 2024, 5: e241756. PMID: 38967949, PMCID: PMC11227074, DOI: 10.1001/jamahealthforum.2024.1756.Peer-Reviewed Original Research
2023
For youth, for Justice
Gavulic K. For youth, for Justice. The Lancet Child & Adolescent Health 2023, 7: 684-685. DOI: 10.1016/s2352-4642(23)00229-8.Commentaries, Editorials and Letters
2022
Recalibrating US Medical School Admissions With an Equity Lens
Gavulic K, Shanab B, Reed-Hendon C. Recalibrating US Medical School Admissions With an Equity Lens. JAMA Health Forum 2022, 3: e224102. PMID: 36367736, DOI: 10.1001/jamahealthforum.2022.4102.Commentaries, Editorials and LettersMedicaid and Accelerated Approval: Spending on Drugs with and without Proven Clinical Benefits
Sachs R, Jazowski S, Gavulic K, Donohue J, Dusetzina S. Medicaid and Accelerated Approval: Spending on Drugs with and without Proven Clinical Benefits. Journal Of Health Politics Policy And Law 2022, 47: 673-690. PMID: 35867545, PMCID: PMC9789165, DOI: 10.1215/03616878-10041107.Peer-Reviewed Original ResearchChanges in the Use of Hydroxyprogesterone Caproate Injection After Confirmatory Trial Failure
Sachs R, Gavulic K, Donohue J, Dusetzina S. Changes in the Use of Hydroxyprogesterone Caproate Injection After Confirmatory Trial Failure. JAMA Internal Medicine 2022, 182: 226-227. PMID: 34870694, PMCID: PMC8649909, DOI: 10.1001/jamainternmed.2021.7001.Peer-Reviewed Original Research
2021
Recent Trends in Medicaid Spending and Use of Drugs With US Food and Drug Administration Accelerated Approval
Sachs R, Gavulic K, Donohue J, Dusetzina S. Recent Trends in Medicaid Spending and Use of Drugs With US Food and Drug Administration Accelerated Approval. JAMA Health Forum 2021, 2: e213177. PMID: 35977163, PMCID: PMC8727037, DOI: 10.1001/jamahealthforum.2021.3177.Peer-Reviewed Original ResearchPrescription Drug Priorities under the Biden Administration
Gavulic K, Dusetzina S. Prescription Drug Priorities under the Biden Administration. Journal Of Health Politics Policy And Law 2021, 46: 599-609. PMID: 33503239, DOI: 10.1215/03616878-8970810.Commentaries, Editorials and Letters
Academic Achievements & Community Involvement
News
News
- August 13, 2024Source: Medical Xpress
Study finds the LGBTQI+ population have less access to health care, worse health outcomes, less insurance
- August 12, 2024Source: Yale News
Insights & Outcomes: Sea scorpions, delusions, and forensics-related stress
- May 10, 2024
Building Capacity in Medical Students to Care for Transgender and Gender Diverse Patients
- October 19, 2022
New Haven Voices